标题
Nicotinic acid: clinical considerations
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume 11, Issue 4, Pages 551-564
出版商
Informa Healthcare
发表日期
2012-05-08
DOI
10.1517/14740338.2012.682981
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Acetylsalicylic Acid Reduces Niacin Extended-Release-Induced Flushing in Patients with Dyslipidemia
- (2013) Roopal B. Thakkar et al. American Journal of Cardiovascular Drugs
- Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
- (2011) Martina Lukasova et al. JOURNAL OF CLINICAL INVESTIGATION
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
- (2010) Carlos Hernandez et al. Cell Metabolism
- Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
- (2010) Michael S. Kostapanos et al. Current Vascular Pharmacology
- Nicotinic acid– and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
- (2010) Julien Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
- (2010) Todd C. Villines et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association between extended-release niacin treatment and glycemic control in patients with type 2 diabetes mellitus: analysis of an administrative-claims database
- (2010) Baishali M. Ambegaonkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
- (2009) Darbie Maccubbin et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
- (2009) Eric Bruckert et al. ATHEROSCLEROSIS
- Niacin improves renal lipid metabolism and slows progression in chronic kidney disease
- (2009) Kyu-hyang Cho et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy
- (2009) Sajoscha A. Sorrentino et al. CIRCULATION
- Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: A post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients
- (2009) Harold E. Bays et al. CLINICAL THERAPEUTICS
- Whatʼs the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush?
- (2009) Harold E Bays et al. CURRENT OPINION IN LIPIDOLOGY
- Standards of Medical Care in Diabetes--2010
- (2009) DIABETES CARE
- The mechanism and mitigation of niacin-induced flushing
- (2009) V. S. Kamanna et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effects of Aspirin When Added to the Prostaglandin D2Receptor Antagonist Laropiprant on Niacin-Induced Flushing Symptoms
- (2009) Victor Dishy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Niacin on Glucose Control in Patients With Dyslipidemia
- (2009) Ronald B. Goldberg et al. MAYO CLINIC PROCEEDINGS
- The Effect of Body Mass Index on Fasting Blood Glucose and Development of Diabetes Mellitus After Initiation of Extended-Release Niacin
- (2009) Ardelle Libby et al. Metabolic Syndrome and Related Disorders
- Comparison of the Safety and Efficacy of a Combination Tablet of Niacin Extended Release and Simvastatin vs Simvastatin Monotherapy in Patients With Increased Non–HDL Cholesterol (from the SEACOAST I Study)
- (2008) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins
- (2008) Stefania Lamon-Fava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice
- (2008) José W.A. van der Hoorn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells
- (2008) Shobha H. Ganji et al. ATHEROSCLEROSIS
- Extended-Release Niacin/Laropiprant: Reducing Niacin-Induced Flushing to Better Realize the Benefit of Niacin in Improving Cardiovascular Risk Factors
- (2008) John F. Paolini et al. CARDIOLOGY CLINICS
- Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire©: results from a randomised placebo-controlled clinical trial
- (2008) J. F. Paolini et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
- (2008) D. Maccubbin et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Flushing and the HDL-C response to extended-release niacin
- (2008) Allen J. Taylor et al. Journal of Clinical Lipidology
- Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL
- (2008) Lin-Hua Zhang et al. JOURNAL OF LIPID RESEARCH
- Is raising HDL a futile strategy for atheroprotection?
- (2008) Tisha Joy et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search